Prochaska Judith J, Hall Sharon M, Humfleet Gary, Munoz Ricardo F, Reus Victor, Gorecki Julie, Hu Dixie
Department of Psychiatry, University of California, San Francisco, 401 Parnassus Avenue, Box TRC-0984, San Francisco, CA 94143-0984, USA.
Prev Med. 2008 Aug;47(2):215-20. doi: 10.1016/j.ypmed.2008.05.006. Epub 2008 May 16.
For smoking cessation, physical activity (PA) may help manage withdrawal symptoms, mood, stress, and weight; yet studies of PA as an aid for smoking cessation have been mixed. This study examined: (1) the impact of an extended relapse prevention program on increasing moderate to vigorous PA (MVPA) in adults enrolled in a tobacco cessation treatment trial; (2) whether changes in MVPA were associated with sustained abstinence from smoking; and (3) mechanisms by which MVPA may support sustained abstinence from smoking.
In a randomized controlled trial conducted from 2003-2006 in San Francisco, California, 407 adult smokers received a 12 week group-based smoking cessation treatment with bupropion and nicotine patch with the quit date set at week 3. At week 12, participants were randomized to no further treatment or to 40 weeks of bupropion or placebo with or without an 11-session relapse prevention intervention of which 2 sessions (held at weeks 16 and 20) focused on PA. Participants receiving the PA intervention (n=163) received a pedometer, counseling to increase steps 10% biweekly towards a 10,000 steps/day goal, and personalized reports graphing progress with individualized goals. The International Physical Activity Questionnaire assessed weekly minutes of MVPA at baseline and weeks 12 and 24. Sustained abstinence from tobacco at week 24 was validated with expired carbon monoxide.
In a repeated mixed model analysis, intervention participants significantly increased their MVPA relative to control participants, F(1,475)=3.95, p=.047. Pedometer step counts also increased significantly, t(23)=2.36, p=.027, though only 15% of intervention participants provided 6 weeks of pedometer monitoring. Controlling for treatment condition, increased MVPA predicted sustained smoking abstinence at week 24, odds ratio=1.84 (95% CI: 1.07, 3.05). Among participants with sustained abstinence, increased MVPA was associated with increased vigor (r=0.23, p=.025) and decreased perceived difficulty with staying smoke-free (r=-0.21, p=.038).
PA promotion as an adjunct to tobacco treatment increases MVPA levels; changes in MVPA predict sustained abstinence, perhaps by improving mood and self-efficacy.
对于戒烟而言,体育活动(PA)可能有助于控制戒断症状、情绪、压力和体重;然而,关于PA作为戒烟辅助手段的研究结果并不一致。本研究旨在探讨:(1)一项延长的预防复吸计划对参加戒烟治疗试验的成年人增加中等至剧烈PA(MVPA)的影响;(2)MVPA的变化是否与持续戒烟相关;以及(3)MVPA可能支持持续戒烟的机制。
2003年至2006年在加利福尼亚州旧金山进行的一项随机对照试验中,407名成年吸烟者接受了为期12周的基于小组的戒烟治疗,使用安非他酮和尼古丁贴片,戒烟日期设定在第3周。在第12周时,参与者被随机分为不再接受进一步治疗、接受40周安非他酮或安慰剂治疗,以及接受或不接受为期11节的预防复吸干预,其中2节(在第16周和第20周进行)侧重于PA。接受PA干预的参与者(n = 163)获得一个计步器,接受每两周将步数增加10%以达到每天10000步目标的咨询,并收到个性化报告,以图表形式展示朝着个性化目标取得的进展。国际体力活动问卷在基线、第12周和第24周评估每周MVPA的分钟数。第24周的持续戒烟情况通过呼出一氧化碳进行验证。
在重复混合模型分析中,与对照组参与者相比,干预组参与者的MVPA显著增加,F(1,475)=3.95,p = 0.047。计步器步数也显著增加,t(23)=2.36,p = 0.027,尽管只有15%的干预组参与者提供了6周的计步器监测数据。在控制治疗条件的情况下,MVPA的增加预测了第24周的持续戒烟情况,优势比 = 1.84(95%置信区间:1.07, 3.05)。在持续戒烟的参与者中,MVPA的增加与活力增加相关(r = 0.23,p = 0.025),与感觉保持无烟的难度降低相关(r = -0.21,p = 0.038)。
将PA推广作为烟草治疗的辅助手段可提高MVPA水平;MVPA的变化预测持续戒烟,可能是通过改善情绪和自我效能感实现的。